Newer drugs in hypertension; combined effects of 1-hydrazinophthalazine (apresoline) and hexamethonium salts; a preliminary report.
D002317:Cardiovascular Agents; D018738:Hexamethonium; D006830:Hydralazine; D006973:Hypertension / Q000628:therapy*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D012492:Salts; D013565:Sympatholytics / Q000627:therapeutic use*
D002317:Cardiovascular Agents; D009125:Muscle Relaxants, Central; D012492:Salts; D013565:Sympatholytics; D006830:Hydralazine; D018738:Hexamethonium
HYPERTENSION/therapy; MUSCLE RELAXANTS/therapeutic use; SYMPATHOLYTICS/therapeutic use